Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (401-410 of 511) with videos related to

Pageof 52
Sort By:
British Journal of Cancer|September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutationL de Plater, A Laugé, C Guyader, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 13, 2021
Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysisF Mone, R Y Eberhardt, M E Hurles, et al.
Molecular Cancer Therapeutics|June 17, 2017
Modeling Therapy Resistance in <i>BRCA1/2</i>-Mutant CancersAmy Dréan, Chris T Williamson, Rachel Brough, et al.
Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.
Breast Cancer Research and Treatment|April 27, 2012
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorElizabeth Iorns, Toby M Ward, Sonja Dean, et al.
Science (New York, N.Y.)|April 4, 2020
Structural basis for allosteric PARP-1 retention on DNA breaksLevani Zandarashvili, Marie-France Langelier, Uday Kiran Velagapudi, et al.
Elife|July 21, 2025
Layilin regulates Treg motility and suppressive capacity in skinVictoire Gouirand, Sean Clancy, Courtney Macon, et al.
Oncogene|January 22, 2013
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependenciesK-K Shiu, D Wetterskog, A Mackay, et al.
Breast Cancer Research and Treatment|August 10, 2012
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparibAnneleen Daemen, Denise M Wolf, James E Korkola, et al.
Molecular & Cellular Proteomics : MCP|April 5, 2023
Quantitative Proteomic Analysis Reveals apoE4-Dependent Phosphorylation of the Actin-Regulating Protein VASPZeynep Cakir, Samuel J Lord, Yuan Zhou, et al.
Pageof 52

Showing results (401-410 of 511) with videos related to

Sort By:
Pageof 52
British Journal of Cancer|September 30, 2010
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutationL de Plater, A Laugé, C Guyader, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 13, 2021
Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysisF Mone, R Y Eberhardt, M E Hurles, et al.
Molecular Cancer Therapeutics|June 17, 2017
Modeling Therapy Resistance in <i>BRCA1/2</i>-Mutant CancersAmy Dréan, Chris T Williamson, Rachel Brough, et al.
Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.
Breast Cancer Research and Treatment|April 27, 2012
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorElizabeth Iorns, Toby M Ward, Sonja Dean, et al.
Science (New York, N.Y.)|April 4, 2020
Structural basis for allosteric PARP-1 retention on DNA breaksLevani Zandarashvili, Marie-France Langelier, Uday Kiran Velagapudi, et al.
Elife|July 21, 2025
Layilin regulates Treg motility and suppressive capacity in skinVictoire Gouirand, Sean Clancy, Courtney Macon, et al.
Oncogene|January 22, 2013
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependenciesK-K Shiu, D Wetterskog, A Mackay, et al.
Breast Cancer Research and Treatment|August 10, 2012
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparibAnneleen Daemen, Denise M Wolf, James E Korkola, et al.
Molecular & Cellular Proteomics : MCP|April 5, 2023
Quantitative Proteomic Analysis Reveals apoE4-Dependent Phosphorylation of the Actin-Regulating Protein VASPZeynep Cakir, Samuel J Lord, Yuan Zhou, et al.
Pageof 52